Serial Number | 98256358 |
Word Mark | ACCESS DAXXIFY |
Filing Date | Monday, November 6, 2023 |
Status | 748 - STATEMENT OF USE - TO EXAMINER |
Status Date | Saturday, June 14, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, September 3, 2024 |
Goods and Services | Financial management of patient reimbursement programs; Financial administration of medication reimbursement programs; Providing patient financial support services, namely, providing insurance information to help patients understand their insurance and plan benefits, providing insurance claims processing information in the nature of information about insurance authorization forms and appeals, and providing insurance reimbursement assistance to eligible patients in the nature of reimbursement payment processing in the field of health and pharmaceutical insurance claims |
International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 1, 2023 |
Primary Code | 036 |
First Use Anywhere Date | Tuesday, May 7, 2024 |
First Use In Commerce Date | Tuesday, May 7, 2024 |
Party Name | Revance Therapeutics, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Newark, CA 94560 |
Party Name | Revance Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Newark, CA 94560 |
Event Date | Event Description |
Friday, December 1, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, November 9, 2023 | NEW APPLICATION ENTERED |
Friday, June 14, 2024 | ASSIGNED TO EXAMINER |
Monday, June 17, 2024 | NON-FINAL ACTION WRITTEN |
Thursday, June 27, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, July 31, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Monday, June 17, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, June 17, 2024 | NON-FINAL ACTION E-MAILED |
Thursday, June 27, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, June 27, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, August 14, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, September 3, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, September 3, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Saturday, March 15, 2025 | USE AMENDMENT FILED |
Saturday, March 15, 2025 | TEAS STATEMENT OF USE RECEIVED |
Wednesday, April 2, 2025 | ASSIGNED TO EXAMINER |
Thursday, June 12, 2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Saturday, June 14, 2025 | STATEMENT OF USE PROCESSING COMPLETE |
Tuesday, October 29, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |